Federal Register / Vol. 65, No. 192 / Tuesday, October 3, 2000 / Notices 59005

3. Continued accessibility of RTECS

to the international scientific

community. The Licensee must make

RTECS continuously available worldwide and market the Database in a

variety of formats including, but not

limited to on-line, CD–ROM, and the

Internet.

4. Multiple point and free access to

NIOSH of all RTECS products. The

Licensee will provide NIOSH research

and information staff with multiple

point and free access to RTECS to

accommodate NIOSH users at six

NIOSH sites, maximum usage not to

exceed 25 users.

5. NIOSH representation on editorial

or policy board or committee. A NIOSH

representative will be designated to

serve on any editorial or policy board

established for the Database to ensure

that the interests of the Institute are

considered. This representative will

serve in a consultative capacity without

decision-making authority.

General Terms

1. Ownership of the RTECS

trademark will be retained by NIOSH.

2. The licensing agreement can be

terminated by either party.

3. Ownership of data files, microfiche,

and other files. NIOSH will retain

ownership of the last RTECS Master

File produced with NIOSH funds. The

Licensee will retain ownership of all

new data generated and indexed under

this agreement. NIOSH will also retain

ownership of the microfiche collection

of the bibliographical references. The

full hard copy collection of the same

references will be delivered to the

Licensee, along with the annual

microfiche editions produced after

1987. In the event of a termination of

the Licensing Agreement, the hard copy

collection and annual microfiche

additions will be returned to NIOSH.

4. Duration of agreement will be

negotiated in the license.

5. In submitted proposals, each

requirement shall be addressed

individually.

Linda Rosenstock,

Director, National Institute for Occupational

Safety and Health, Centers for Disease Control

and Prevention.

[FR Doc. 00–25429 Filed 10–02–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Council for the Elimination of

Tuberculosis: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(P.L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following council

meeting.

Name: Advisory Council for the

Elimination of Tuberculosis (ACET).

Times and Dates: 8:30 a.m.–5 p.m.,

October 18, 2000; 8:30 a.m.–12 p.m., October

19, 2000.

Place: Corporate Square, Building 8, 1st

Floor Conference Room, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 100 people.

Purpose: This council advises and makes

recommendations to the Secretary of Health

and Human Services, the Assistant Secretary

for Health, and the Director, CDC, regarding

the elimination of tuberculosis. Specifically,

the Council makes recommendations

regarding policies, strategies, objectives, and

priorities; addresses the development and

application of new technologies; and reviews

the extent to which progress has been made

toward eliminating tuberculosis.

Matters To Be Discussed: Agenda items

include issues pertaining to the IOM Report

on TB Elimination in the U.S. and other TB

related topics.

Contact Person for More Information:

Paulette Ford, National Center for HIV, STD,

and TB Prevention, 1600 Clifton Road, NE,

M/S E–07, Atlanta, Georgia 30333, telephone

404/639–8008.

The Director, Management Analysis

and Services Office, has been delegated

the authority to sign Federal Register

Notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: September 27, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–25322 Filed 10–2–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N–1224]

Agency Information Collection

Activities; Announcement of OMB

Approval; Submitting and Reviewing

Complete Responses to Clinical Holds;

Guidance for Industry

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that a collection of information entitled

‘‘Submitting and Reviewing Complete

Responses to Clinical Holds; Guidance

for Industry’’ has been approved by the

Office of Management and Budget

(OMB) under the Paperwork Reduction

Act of 1995.

FOR FURTHER INFORMATION CONTACT:

Karen L. Nelson, Office of Information

Resources Management (HFA–250),

Food and Drug Administration, 5600

Fishers Lane, Rockville, MD 20857,

301–827–1482.

SUPPLEMENTARY INFORMATION: In the

Federal Register of April, 13, 2000 (65

FR 19910), the agency announced that

the proposed information collection had

been submitted to OMB for review and

clearance under 44 U.S.C. 3507. An

agency may not conduct or sponsor, and

a person is not required to respond to,

a collection of information unless it

displays a currently valid OMB control

number. OMB has now approved the

information collection and has assigned

OMB control number 0910–0445. The

approval expires on September 12,

2003. A copy of the supporting

statement for this information collection

is available on the Internet at http://

www.fda.gov/ohrms/dockets.

Dated: September 26, 2000.

William K. Hubbard,

Senior Associate Commissioner for Policy,

Planning, and Legislation.

[FR Doc. 00–25283 Filed 10–2–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Cardiovascular and Renal Drugs

Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.